EPINEPHRINE
From CRS EMS Guidelines
Revision as of 21:35, 3 April 2022 by Cgabryszek (talk | contribs) (Created page with "'''Class''' Sympathomimetic '''Pharmacology and Actions''' # Catecholamine with alpha and beta effects # Cardiovascular: Increased heart rate, increased blood pressure, arterial vasoconstriction, increased myocardial contractile force, increased myocardial oxygen consumption, and increased myocardial automaticity and irritability # Pulmonary: Potent bronchodilator '''Indications''' # Medical cardiac arrest, including: ## Ventricular fibrillation and pulseless ventri...")
Class
Sympathomimetic
Pharmacology and Actions
- Catecholamine with alpha and beta effects
- Cardiovascular: Increased heart rate, increased blood pressure, arterial vasoconstriction, increased myocardial contractile force, increased myocardial oxygen consumption, and increased myocardial automaticity and irritability
- Pulmonary: Potent bronchodilator
Indications
- Medical cardiac arrest, including:
- Ventricular fibrillation and pulseless ventricular tachycardia, asystole, and PEA
- Bradycardia:
- Pediatric patients with signs of poor perfusion.
- Asthma
- Mild to moderate allergic reactions, anaphylaxis or severe angioedema
- Life-threatening airway obstruction suspected secondary to croup or epiglottitis.
Contraindications
- Epinephrine 1:1000:
- Hypertension
- Pregnancy
- Patients with tachyarrhythmias
- Epinephrine 1:10,000 is for intravenous or endotracheal use; it should not be used in patients who do not require extensive resuscitive efforts.
Precautions
- Do not add to solutions containing bicarbonate.
- Increase in myocardial oxygen consumption can precipitate angina or MI in patients with coronary artery disease.
- Use with caution in patients with hypertension, hyperthyroidism, peripheral vascular disease, or cerebrovascular disease or any patient over the age of 50.
- Asthma is not the only cause of wheezing. Epinephrine is contraindicated in pulmonary edema.
- Anaphylaxis is a systemic allergic reaction with cardiovascular collapse. Angioedema involves swelling of mucous membranes; potential exists for airway compromise. Mild or moderate allergic reactions with urticaria or wheezing may progress to anaphylaxis or severe angioedema. Monitor patient carefully and treat according to patient status.
- Epinephrine comes in two strengths. Use of the wrong formulation will result in a ten-fold difference in dosage. Be sure to use the right one.
Administration
- Adult
- Cardiac arrest
- 1.0 mg (10 mL of 1:10,000 solution) IV/IO every 3-5 minutes
- Moderate or severe allergic reactions
- 0.3 (0.3 mL of 1:1000 solution) SQ/IM
- Anaphylaxis
- Consider administration of Epinephrine 0.1 mL of 1:1,000 solution or 1 mL of 1:10,000 solution IV/IO for refractory anaphylactic shock. Dilute with 9-10 mL NS or administer with IV running wide open
- Asthma
- 0.3 (0.3 mL of 1:1000 solution) SQ/IM
- Cardiac arrest
- Pediatric
- Cardiac arrest
- IV/IO dose: 0.01 mg/kg (0.1 mg/kg of 1:10,000 concentration). Administer every 3 to 5 minutes during arrest.
- All tracheal doses: 0.1 mg/kg (0.1mL/kg of 1:1000 concentration). Note: Administer every 3-5 minutes of arrest until IV/IO access achieved; then begin with first IV dose.
- Symptomatic Bradycardia
- All IV/IO doses: 0.01 mg/kg (0.1 mL/kg of 1:10,000 concentration).
- All tracheal doses: 0.1 mg/kg (0.1 mL/kg of 1:1000 concentration).
- Mild or Moderte allergic reactions
- 0.01 mg/kg (0.01 mL/kg of 1:1000 solution) SQ/IM
- Anaphylaxis (Contact medical control)
- 0.01 mg/kg (0.1 mL/kg of 1:10,000 solution) IV/IO.
- Asthma
- 0.01 mg/kg (0.1 mL/kg of 1:1000 solution) SQ/IM
- Cardiac arrest
- IV doses may be given through ET at 10 times the IV dose.
Side Effects and Special Notes
- Anxiety, tremor, palpitations, vomiting, and headache are common.